-
Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Pat
firstwordpharma
August 16, 2021
Enlivex Therapeutics Ltd. today reported that after reviewing previously-reported Phase II trial data, the Israeli Ministry of Health has authorized the initiation of a proposed Company-sponsored, multi-center, placebo-controlled, randomized, blinded
-
Bio firms raising alert over vaccine tech theft
firstwordpharma
August 16, 2021
The Korea Biotechnology Industry Organization (Korea Bio) is issuing warnings against practices by Chinese entities attempting to steal technology vital to COVID-19 vaccines amid the pandemic, reported The Korea Herald.
-
Swedish researchers planning to hold Covid-19 nasal vaccine trial in Bangladesh
firstwordpharma
August 16, 2021
Swedish researchers are gearing up to seek permission from Bangladeshi authorities to hold clinical trials of a nasal COVID-19 vaccine in the country, reported the Dhaka Tribune.
-
Australia purchases Pfizer vaccines from Poland as COVID-19 infections spike
firstwordpharma
August 16, 2021
Australia has bought about 1 million doses of Pfizer's COVID-19 vaccine from Poland to bolster its inoculation efforts in Sydney and its home state of New South Wales, as reported in Investing.com.
-
All young people aged 16 and 17 in England to be offered vaccine by next week
firstwordpharma
August 16, 2021
Tens of thousands of people in this age group have already been vaccinated at local vaccination sites and walk-in centres across the country and the drive to offer a first jab by the new date will allow those teenagers in that age bracket the two weeks.
-
S. Korea urges rapid vaccine supply during protest visit to Moderna
firstwordpharma
August 16, 2021
South Korea has asked Moderna to speed up its delivery of COVID-19 vaccines to Seoul in accordance with a prior contract, reported The Korea Herald.
-
Sinovac to apply for clinical trial of Delta-specific vaccine in Q3: general manager
firstwordpharma
August 16, 2021
Sinovac plans to submit clinical application materials for its inactivated COVID-19 vaccine especially for the Delta variant to authorities in the third season this year, reported the Global Times.
-
Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals
prnewswire
August 16, 2021
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals
-
Pharmaceutical Gelatin Market's COVID-19 Impact and Recover Analysis Procurement Intelligence Report | SpendEdge
prnewswire
August 16, 2021
The Pharmaceutical Gelatin market is poised to grow by USD 210.1 Million, progressing at a CAGR of almost 6.54%during the forecast period.
-
Pharmaceutical Robots Market to Exceed USD 383.91 million by 2028 - COVID-19 Impact and Global Analysis by The Insight Partners
prnewswire
August 16, 2021
As per the latest The Insight Partners research report, "Pharmaceutical Robots Market to 2028 – Global Analysis and Forecast – by Product, Application, End User, and Geography," the market is projected to reach US$ 383.91 million by 2028 from US$ 159.23.